Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2024 value amounting to $3000.0.

  • Lifecore Biomedical, Inc. \De\'s Income towards Parent Company rose 10013.12% to $3000.0 in Q2 2024 from the same period last year, while for Feb 2025 it was $3000.0, marking a year-over-year decrease of 9923.66%. This contributed to the annual value of $2.7 million for FY2024, which is 10759.19% up from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Income towards Parent Company of $3000.0 as of Q2 2024, which was up 10013.12% from $847000.0 recorded in Q1 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Income towards Parent Company registered a high of $1.9 million during Q3 2023, and its lowest value of -$51.6 million during Q2 2022.
  • Moreover, its 5-year median value for Income towards Parent Company was -$3.6 million (2022), whereas its average is -$10.2 million.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Income towards Parent Company crashed by 241057.11% in 2020, and later surged by 14357.83% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Income towards Parent Company (Quarter) stood at -$4.0 million in 2020, then plummeted by 1039.91% to -$46.0 million in 2021, then skyrocketed by 92.17% to -$3.6 million in 2022, then soared by 99.33% to -$24000.0 in 2023, then skyrocketed by 112.5% to $3000.0 in 2024.
  • Its last three reported values are $3000.0 in Q2 2024, $847000.0 for Q1 2024, and -$24000.0 during Q4 2023.